TRISOMY 18 SUPPORT INC

The goal of the Trisomy 18 Foundation is to make Trisomy 18 a preventable and treatable condition and to ensure that all families have access to compassionate and knowledgeable care that respects the humanity and potential of their child diagnosed with Trisomy 18.

Trisomy 18 Foundation works to accomplish it's goal by:
• educating families, their communities and health professionals about Trisomy 18 and related conditions
• creating a caring worldwide community of affected families maximizing digital strategies to bridge distances
• driving research initiatives and research funding to focus on prevention and treatments, and
• advocating for increased public awareness and federal funding for improving health outcomes for diagnosed children.

The Foundation has built capacities and strengths in key areas to further it's mission:
• An experienced and skilled staff and volunteer network that reaches constituents in all 50 states, Canada, and others Internationally.
• An award-wining technology-enabled cloud-based operational structure that creates significant cost efficiencies in overhead assets that fuel program delivery.
• A diverse Scientific Advisory Board of leading scientists and clinical researchers committed to accelerating interest in biomedical research to identify targets for Trisomy 18 treatments and preventions.
• Innovative leadership in NonProfit communications and social media platforms that engages new supporters in the Trisomy 18 cause.
• Leading programs in Peer-to-Peer Fundraising and User-generated Memorial Pages recognized for best practices in National media.
• Significant brand awareness and SEO contributing to making Trisomy 18 Foundation the leading disease advocacy group focused exclusively on the Trisomy 18 condition.

The Foundation has developed a solid operational infrastructure that provides stability, and have formed a gifted board and staff to ensure responsible stewardship of advancing the Foundation's mission. We are vigilantly working on enhancing experience in Development staffing and Board Leadership to increase our impact and accelerate the rate of research investment. There are many promising areas needing greater levels of investment in Trisomy 18-related projects, each of which offers potential targets for treatments that have the potential to reduce the prevalence rates of Trisomy 18 conceptions and increase the life expectancy of children born with Trisomy 18 in the first year of life. We are committed to working toward these goals in the coming years while we stay singularly focused on quality execution and evaluation of impacts.